Top Markets
Coin of the day
Armata Pharmaceuticals, Inc. Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

ARMP
株式のランク #18285
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology... Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product pipeline are several significant candidates: AP-SA02, designed for the treatment of Staphylococcus aureus bacteremia; AP-PA02, targeting Pseudomonas aeruginosa; and AP-PA03, intended to address pneumonia. Additionally, Armata has forged a collaborative agreement with Merck & Co. to further the development of synthetic bacteriophage candidates aimed at specific, yet unrevealed, infectious disease agents. The company's main offices are located in Marina del Rey, California.
株価
$5.59
最終同期: 2026-09-02
時価総額
$205.21M
変化(1日)
6.27%
変化(1年)
86.33%
US
取引 Armata Pharmaceuticals, Inc. (ARMP)

カテゴリー

Armata Pharmaceuticals, Inc.(ARMP)のP/S比率
2026 時点のP/S比率 TTM: 0
Armata Pharmaceuticals, Inc. の最新の財務報告および株価によると、現在のP/S比率(TTM)は 0 です。2026 年末時点でのP/S比率は 0 でした。
Armata Pharmaceuticals, Inc. の P/S 比率の履歴(2026 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率
企業 P/S比率 P/S比率の差
10.95 -
US
12.19 -
NL
24.99 -
US
3.75 -
AU
- -
CH